PHVS שווי כולל של נכסי החברה Pharvaris NV
Pharvaris N.V. (PHVS) attracts leading biochemists through unique R&D projects and stock options while fostering an ethical corporate culture. Simultaneously, the company is implementing energy-efficient systems and closed-loop water recycling to comply with ESG standards. The price action of exchange-traded quotes for total assets is recorded at 311.00. Growth prospects are based on the patenting of a high-margin oral treatment for hereditary angioedema, which strengthens the issuer's market position.
פילוחים אנליטיים ודוחות נתונים של חברת Pharvaris Corp (PHVS)
This indicator represents a reverse calculation of total assets and liabilities via return on assets, which allows for the stripping of market volatility from the company's fundamental basis. The trend in projected assets and resources reflects the efficiency of innovation capitalization at Pharvaris N.V. (PHVS), where the growth of this metric confirms the scaling of production for unique oral medications used in the therapy of hereditary angioedema.